Related Experiment Video
Updated: Feb 4, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
An RGD small-molecule integrin antagonist induces detachment-mediated anoikis in glioma cancer stem cells
Mayra Paolillo1, Marisa C Galiazzo1, Antonio Daga2
1Department of Drug Sciences, University of Pavia, I-27100 Pavia, Italy.
Abstract:
The malignancy of glioblastoma (GB) is primarily due to the ability of glioma cancer stem cells (GSC) to disseminate into surrounding brain tissues, despite surgery and chemotherapy, and to form new tumoral masses. Members of the RGD-binding integrin family, which recognize the arginine-glycine-aspartic acid (RGD) sequence present in components of the extracellular matrix, and which serve a crucial function in the dissemination of GCS, are overexpressed in GB. Small-molecule integrin antagonists (SMIAs) designed to recognize RGD-integrins may therefore be an effective tool for decreasing GB infiltration and recurrence. In the present study, in vitro pro-apoptotic and infiltrative effects elicited by the SMIA 1a‑RGD in human GSC were investigated. Reverse transcription-quantitative polymerase chain reaction analysis revealed that, compared with normal human astrocytes, GSC grown on laminin-coated dishes overexpressed stemness markers as well as αvβ3 and αvβ5 integrins. In addition, dissociated GSC were identified to exhibit tumorigenic capacity when injected into immunodeficient mice. Using annexin/fluorescence-activated cell sorting analysis and ELISA nucleosome assays, it was identified that treatment of GSC with 25 µM 1a‑RGD for 48 h elicited detachment‑dependent anoikis not accompanied by necrosis-dependent cell death. A colorimetric proliferation assay indicated that 1a‑RGD did not affect cell viability, but that, instead, it markedly inhibited GSC migration as assessed using a Transwell assay. Western blot experiments revealed a decrease in focal adhesion kinase and protein kinase B phosphorylation with a concomitant increase in caspase-9 and -3/7 activity following 1a‑RGD treatment, suggesting that the pro-anoikis effects of 1a‑RGD may be mediated by these molecular mechanisms. Western blot analysis revealed no changes in specific markers of autophagy, suggesting further that 1a‑RGD-induced cell death is primarily sustained by anoikis-associated mechanisms. In conclusion, the results of the present study indicate that SMIA have potential as a therapeutic tool for decreasing GSC dissemination.
Insights
Small-molecule integrin antagonists (SMIAs) show promise in treating glioblastoma. The study found that SMIA 1a-RGD inhibits glioma cancer stem cell migration and induces anoikis, offering a potential therapeutic strategy against tumor recurrence.
Area of Science:
- Neuro-oncology
- Cancer Stem Cell Biology
- Integrin Signaling
Background:
- Glioblastoma (GB) malignancy stems from glioma cancer stem cells (GSCs) disseminating into brain tissue.
- Overexpressed RGD-binding integrins in GB facilitate GSC dissemination.
- Small-molecule integrin antagonists (SMIAs) targeting RGD-integrins may reduce GB infiltration and recurrence.
Purpose of the Study:
- To investigate the in vitro pro-apoptotic and anti-infiltrative effects of the SMIA 1a-RGD on human GSCs.
- To explore the molecular mechanisms underlying the effects of 1a-RGD on GSCs.
Main Methods:
- Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) to analyze gene expression.
- Annexin/fluorescence-activated cell sorting (FACS) and ELISA for cell death assays.
- Colorimetric proliferation and Transwell assays for cell viability and migration.
- Western blot analysis for protein phosphorylation and caspase activity.
Main Results:
- GSCs overexpressed stemness markers and αvβ3/αvβ5 integrins compared to normal astrocytes.
- 1a-RGD treatment induced detachment-dependent anoikis in GSCs without causing necrosis.
- 1a-RGD inhibited GSC migration but did not affect cell viability.
- 1a-RGD decreased focal adhesion kinase and protein kinase B phosphorylation, increasing caspase-9 and -3/7 activity.
Conclusions:
- SMIA 1a-RGD effectively inhibits GSC migration and induces anoikis, suggesting a potential therapeutic approach for glioblastoma.
- The pro-anoikis effects of 1a-RGD appear mediated by the FAK/Akt/caspase pathway.
- 1a-RGD represents a promising therapeutic strategy to reduce GSC dissemination and glioblastoma recurrence.
More Related Videos
05:29A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
Published on: March 28, 2021
05:21Author Spotlight: Optimizing Antibody-Based Cancer Treatments via Antibody-Dependent, Cell-Mediated Cytotoxicity Assay
Published on: September 13, 2024
Related Concept Videos
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic...
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...